Vaccines and US earnings in focus

Vaccines and US earnings in focus 150 150 Realm

In the US, fourth quarter earnings are in focus with major companies including Facebook and Apple, reporting this week. The majority of companies that have already reported have beaten expectations.

On the vaccine front, there is a dispute emerging between the EU and Astrazeneca over supply with the company experiencing production problems but positive news from Moderna who stated its vaccines have shown to protect against new variants of coronavirus.

Investors will also be monitoring the developing political crisis in Italy with Prime Minister Giuseppe Conte expected to resign today.

Disclaimer:  ‘Where the business has expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals and are subject to change without notice. The information contained within this communication is believed to be reliable but Realm Investment Management Limited does not warrant its completeness or accuracy. This communication is not intended as a recommendation to invest in any particular asset class, security or strategy. Regulatory requirements that require impartiality of investment/investment strategy recommendations are therefore not applicable nor are any prohibitions to trade before publication. The information provided is for illustrative purposes only, it should not be relied upon as recommendations to buy or sell investments.’